Raj Arvind Bhanushali and PACs acquired 22,82,507 shares of Aspira Pathlab & Diagnostics Limited for ₹27.53 Cr at ₹120.60 per share, raising their stake from 23.82% to 46.00% pursuant to an open offer.
Aspira Pathlab & Diagnostics Limited is a Mumbai-based pathology and diagnostic healthcare services company established in 1973. It operates multiple diagnostic centers offering pathology tests, sonography, X-ray, 2D echocardiography, and specialized health screening packages. The company holds NABL accreditation and positions itself with over 50 years of experience in diagnostic services. It is listed on the BSE (code 540788) and serves patients through in-center and home-based blood collection services across India.
